Texas Instruments (TXN) shares were up 4.7% in afternoon trading on Friday after Seaport Global upgraded the company's stock to buy from neutral.
Trading volume stood at over 3.7 million shares against a daily average of around 7.2 million.
Price: $312.21, Change: $+13.82, Percent Change: +4.63%
US Trade Rep Greer Says No Imminent Chip Tariffs Expected, Reuters Reports
Summit Therapeutics (SMMT) shares fell nearly 2% in intraday trading on Friday after HC Wainwright downgraded the stock to neutral from buy.Trading volume stood at about 4.2 million shares, compared with a daily average of over 3.4 million.Price: $17.15, Change: $-0.32, Percent Change: -1.83%
Gilead Sciences (GILD) has received approval from the US Food and Drug Administration for Hepcludex to treat chronic hepatitis delta virus infection in adults without advanced liver scarring, or with compensated cirrhosis, the FDA said Friday.The therapy is the first FDA-approved treatment for chronic HDV infection, a serious condition that can cause liver fibrosis, liver cancer, liver failure, and even death, the regulator said.The efficacy of Hepcludex was shown in a phase 3 trial, it said.Shares were up over 2% in afternoon trading.Price: $133.74, Change: $+3.24, Percent Change: +2.48%